These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4795285)

  • 21. [Experimental and clinical studies using I-131 BSP].
    Mostbeck A; Peschl L; Rettenbacher-Täubner H; Neumayr A
    Z Gastroenterol; 1974 Nov; 12(7):547-56. PubMed ID: 4440045
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experiences with the BSP double retention test in Tichý's modification].
    Pelikán V; Seidlovà V; Vrublovskỳ P; Sànovà J
    Cesk Gastroenterol Vyz; 1971; 25(5):192-8. PubMed ID: 5162970
    [No Abstract]   [Full Text] [Related]  

  • 23. [Isolated pathology of BSP excretion. Study of 4 patients].
    de Groote J; Ramboer C; Versieck J; Barbier F
    Rev Int Hepatol; 1968; 18(6):833-44. PubMed ID: 5702104
    [No Abstract]   [Full Text] [Related]  

  • 24. I-BSP scanning of the liver.
    Suwanik R; Viranuvatti V; Limwongse K; Hitanant S; Pleehachinda R
    Am J Proctol; 1966 Dec; 17(6):462-70. PubMed ID: 5980690
    [No Abstract]   [Full Text] [Related]  

  • 25. A new look at the plasma disappearance of sulfobromophthalein (BSP): correlation with the BSP transport maximum and the hepatic plasma flow in man.
    Häcki W; Bircher J; Preisig R
    J Lab Clin Med; 1976 Dec; 88(6):1019-31. PubMed ID: 993641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The double retention test BSP (bromsulphalein)].
    Tichý JA
    Vnitr Lek; 1970 Feb; 16(2):146-9. PubMed ID: 4907669
    [No Abstract]   [Full Text] [Related]  

  • 27. [The sulfobromophthalein test: clinical results with a new method of interpretation].
    Barbi G; Sardini D; Tallone G
    Minerva Med; 1968 May; 59(37):2210-3. PubMed ID: 5649326
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings: An approach to the diagnosis of liver disorders using 123I-BSP.
    Reuben A; Narasimah K; Myers M; Wood T; Britton K
    Gut; 1974 Oct; 15(10):837. PubMed ID: 4434961
    [No Abstract]   [Full Text] [Related]  

  • 29. The new clearance method for hepatic diagnostics.
    Tichý JA; Loucka M; Trefný ZM
    Prague Med Rep; 2005; 106(3):229-42. PubMed ID: 16463581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic value of the combined BSP-indocyanine green test with continuous recording].
    Lemonnier F; Chevrel B; Caroli J
    Pathol Biol (Paris); 1969; 17(15):687-95. PubMed ID: 4907900
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical value of liver function appraisal by means of 131-I-rose bengal. 3. Comparison of the results of 131-I-rose bengal test and BSP test.
    Dobrzański Z; Toth Z
    Pol Med J; 1970; 9(3):599-603. PubMed ID: 5460555
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies of the function of the liver in chronic impairment by observing the glucuronization of o-iodobenzoic acid I-131 and bromsulphalein (BSP) and rose bengal-I-131 tests].
    Martínek K; Dohnálek J; Eysselt M; Huvar A
    Vnitr Lek; 1968 Sep; 14(9):878-84. PubMed ID: 5688648
    [No Abstract]   [Full Text] [Related]  

  • 33. [BSP in pregnancy (author's transl)].
    Zeilicoff R; Perelstein GI; Gilardoni A; Schon M
    Acta Gastroenterol Latinoam; 1973; 5(2):65-9. PubMed ID: 4768783
    [No Abstract]   [Full Text] [Related]  

  • 34. [What does the BSP retention measure? Comparison of BSP-transport maximum, storage capacity and capacity for elimination of galactose].
    Imesch B; Häcki W; Bircher J
    Schweiz Med Wochenschr; 1973 Mar; 103(11):397-403. PubMed ID: 4691799
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic sulfobromophthalein uptake and storage defect in a dog.
    Strombeck DR; Qualls C
    J Am Vet Med Assoc; 1978 Jun; 172(12):1423-6. PubMed ID: 670045
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hepatic clearence of bromosulphalein (BSF) in jaundice].
    Bordas JM; Bruguera M; Rodes J; Teres J
    Rev Esp Enferm Apar Dig; 1969 Jan; 28(1):57-92. PubMed ID: 4884768
    [No Abstract]   [Full Text] [Related]  

  • 37. [The Zimmer test (two dye test) in primary hepatic diseases].
    Manzini A; Rimondini R; Ruffilli E
    Bull Sci Med (Bologna); 1968; 140(4):345-57. PubMed ID: 5719610
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum concentration of bile acids as an index of liver lesions in rheumatoid arthritis].
    Altomonte L; Negrini AP; De Cunto F; Sommella L; Greco AV; Magarò M
    Minerva Med; 1982 Jun; 73(24):1695-8. PubMed ID: 6123967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.